LeonaBio, Inc. Common Stock LONA Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $24.46M+39.8% | $17.5M-13.2% | $20.16M-42.8% | $35.26M-34.4% | $53.75M-24.0% | ||
| $18.33M+9.9% | $16.68M-12.7% | $19.11M-15.6% | $22.63M-9.0% | $24.88M-4.7% | ||
| $109.94M+7.5% | $102.27M+160% | $39.27M-36.7% | $62.01M-25.1% | $82.75M-18.0% | ||
| -$109.94M-7.5% | -$102.27M-160% | -$39.27M+36.7% | -$62.01M+25.1% | -$82.75M+18.0% | ||
| $1.43M+15.6% | $1.24M-19.9% | $1.54M-28.6% | $2.16M-28.1% | $3.01M-24.2% | ||
| -$129.41M-22.5% | -$105.61M-180% | -$37.72M+37.0% | -$59.85M+24.9% | -$79.75M+17.7% | ||
| -$22.49+2.6% | -$23.10-187% | -$8.06+41.8% | -$13.84+3.6% | -$14.36-13.0% | ||
| -$109.07M-7.6% | -$101.38M-164% | -$38.38M+37.2% | -$61.13M+25.3% | -$81.87M+18.1% | ||
| -$109.94M-7.5% | -$102.27M-160% | -$39.27M+36.7% | -$62.01M+25.1% | -$82.75M+18.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is LeonaBio, Inc. Common Stock profitable?
- LeonaBio, Inc. Common Stock is not currently profitable: it reported a net loss of $129.4M over the trailing twelve months.
- What is LeonaBio, Inc. Common Stock's earnings per share?
- LeonaBio, Inc. Common Stock's diluted EPS over the trailing twelve months is $-22.49.
- Where does LeonaBio, Inc. Common Stock's income statement data come from?
- Every line is extracted from LeonaBio, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.